Manifold Bio
Boston, USWebsite
Company-aware practice
Start company interviewLoading company information...
Company context
Manifold Bio prompts can include culture, product, and business context from this profile.
Role targeting
Pair this profile with an open role to generate focused behavioral and technical questions.
Answer coaching
Practice responses, get feedback, and refine stories before applying or interviewing.
Manifold Bio is a Boston-based biotechnology company dedicated to revolutionizing drug discovery by bridging the gap between AI-driven protein design and high-throughput in vivo experimentation. Founded in 2019 by pioneers from the Wyss Institute at Harvard, the company addresses the 'translational barrier' in drug development by utilizing its proprietary mDesign platform. This technology allows for the simultaneous testing of hundreds of therapeutic candidates within living systems, providing a feedback loop that enables AI to learn directly from complex biological environments.
Manifold Bio’s mission is to make the best life-saving drugs available to patients as quickly as possible by unlocking the full potential of AI-guided drug design with drastically increased experimental throughput in living systems.
Founded
2019
Headquarters
Boston, Massachusetts
Employees
50
Industry
Biotechnology
Opportunity to work at the intersection of cutting-edge AI and synthetic biology.
High-impact work environment focused on solving critical clinical challenges like drug toxicity.
High-pressure environment typical of early-stage biotech startups.
The complexity of the platform requires a steep learning curve for new hires.
Funding
$78 million
CEO
Dr. Gleb Kuznetsov